Back to UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

ABTABT
Showing 8 of 31 quarters

Position history for UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLCUBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's holdings in ABBOTT LABORATORIES

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds 12.8M shares of ABT (ABBOTT LABORATORIES), worth $1.2B as of 2026-Q2. The position was decreased (-2.8% shares). ABT represents 0.2% of UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's portfolio.

Current Value

$1.2B

Current Shares

12.8M

Total Value Change

+$112M

Total Shares Change

+3.6M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
12.8M
-2.8%
$1.2B0.2%$90.10
0
2026-Q1
Increased
13.2M
+19.4%
$1.4B0.3%$101.31
45
2025-Q4
Increased
11.1M
+5.8%
$1.4B0.3%$123.00
40
2025-Q3
Decreased
10.5M
-18.0%
$1.4B0.3%$130.91
0
2025-Q2
Increased
12.7M
+22.1%
$1.7B0.4%$132.34
46
2025-Q1
Decreased
10.4M
-2.1%
$1.4B0.4%$128.48
0
2024-Q4
Increased
10.7M
+15.5%
$1.2B0.3%$108.98
44
2024-Q3
Decreased
9.2M
-5.9%
$1.1B0.3%$109.33
0

Other major holders of ABT: BNP PARIBAS FINANCIAL MARKETS, VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used